SCHEMBL7385804

SCHEMBL7385804

CC(=O)SCC1CCCCCCCCCCC(C(=O)O)NC1=O

nearest known ligand 0.62

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ACE P12821 11/20 0.46
MME P08473 13/20 0.45
ECE1 P42892 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7386472 1.00 ACE (0.46) ACEMMEECE1
SCHEMBL7386691 0.87 ACE (0.42) ACEMME
SCHEMBL7385917 0.87 ACE (0.41) ACEMME
SCHEMBL7387304 0.87 ACE (0.41) ACEMME
SCHEMBL7388912 0.86 ACE (0.40) ACEMME
SCHEMBL7382068 0.85 ACE (0.40) ACEMME
SCHEMBL4543500 0.80 MME (0.72) ACEMME
SCHEMBL7386461 0.79 TSHR (0.50) ACEMME
SCHEMBL7392789 0.77 ACE (0.35) ACE
SCHEMBL7392788 0.77 ACE (0.35) ACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5426103-A Endopeptidase inhibitors; condensing macrocylic compound with a thioic acid or salt therof; possible esterification, salt formation, deslating, deprotecting, deesterifying of function-al groups CIBA-GEIGY CORPORATION (US) 1995-06-20 US disclosed
US-5244889-A Treatment of cardiovascular disorders CIBA-GEIGY CORPORATION (US) 1993-09-14 US disclosed
EP-0544620-A1 Macrocyclic lactams as inhibitors of atrial natriuretic factors (ANF)-degrading neutral endopeptidase (NEP) CIBA-GEIGY AG (CH) 1993-06-02 EP disclosed